Beta-1-Adrenergic Receptor Antibodies in Acute Coronary Syndrome: Is Less Sometimes More?

Front Cardiovasc Med · 2018 · PMC6305491 · PMID 30619882

Europe PMC DOI

hedged sentences

0.2700

closest p · 5.4× alpha

0.4900

boldest claim

The sentences

failed to reach significancep = 0.27not close (p > 0.1)

Again, the Spearman's Rank correlation failed to reach significance ( p = 0.27), suggesting that anti-β 1 AR Ab does not relate to atherosclerosis directly.

also in 4,113 other papers

did not achieve significancep = 0.49not close (p > 0.1)

The median symptom duration among STEMI patients appeared shorter at 3.7 [2.9–9.0] h, but the inter-group differences did not achieve significance ( p = 0.49).

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.